ITL News & Events
Results of AGM 2020
Company to delist from the ASX last trading day 8th February 2019
The shareholders have voted overwhelmingly to remove ITL Health Group Limited from the official list of the ASX at the Extraordinary General Meeting held today at 10:00 am.
Read More “Company to delist from the ASX last trading day 8th February 2019”
ITL Health Group Limited January 2019 Extraordinary General Meeting Results
Voluntary Delisting from ASX—ITL Health Group Limited (ASX:ITD)
ITL Health Group Limited (‘ITL’) has today, following a resolution of the Board of Directors, submitted a formal application for the removal of ITL’s fully paid ordinary shares (‘Shares’) from the Official List of Australian Securities Exchange (‘ASX’) pursuant to ASX Listing Rule 17.11.
Read More “Voluntary Delisting from ASX—ITL Health Group Limited (ASX:ITD)”
ITL Health Group Announces 2017/18 Results
ITL Health Group (ASX:ITD), a manufacturer and seller of medical technology to the global blood industry and developer of innovative direct-to-consumer pathology testing services, announces results for the year ended 30 June 2018.
ITL Health Group Featured on Biotech Daily
ITL Health Group (ASX:ITD) was featured on Biotech Daily, a website which provides daily news on ASX-listed biotechnology companies.
Friday, 29th June 2018
Dr Boreham’s Crucible: ITL Health
Read article → Biotech Daily ITL Health Group Jun 29 2018
ITL BioMedical Launches Safety SubCulture Unit 2
ITL Health Group (ASX:ITD) is pleased to announce the launch of ITL BioMedical’s latest innovative product to support the microbiology laboratory blood culture testing process. The Safety SubCulture Units 2 (SCU2) is one of a pipeline of new products to be brought to market in the current financial year.
Read More “ITL BioMedical Launches Safety SubCulture Unit 2”
ITL BioMedical Launches More New Blood Sector Products
ITL Health Group (ASX:ITD) is pleased to announce the launch of ITL BioMedical’s latest pre-analytical products for blood culture sample collection, SampLok® Adapter Cap 2 and SampLok® Adapter Cap 3.
Read More “ITL BioMedical Launches More New Blood Sector Products”
ITL BioMedical’s hot pink HR initiative makes tracks in CEO Magazine
A unique HR initiative by ITL BioMedical, which involved giving hot pink Yamaha scooters to employees at its manufacturing facility in Ipoh, Malaysia, has been profiled in CEO Magazine.
Read More “ITL BioMedical’s hot pink HR initiative makes tracks in CEO Magazine”
